The Board of Trustees of the Foundation for Managed Care Pharmacy (FMCP), the educational and philanthropic arm of the Academy of Managed Care Pharmacy (AMCP), has announced the appointment of 4 new FMCP Trustees.
The Board of Trustees of the Foundation for Managed Care Pharmacy (FMCP), the educational and philanthropic arm of the Academy of Managed Care Pharmacy (AMCP), has announced the appointment of 4 new FMCP Trustees.
They are:
• Suzanne Blackburn, senior vice president, new markets business and product services for Medco Health Solutions;
• Annette Boyer, vice president of business development for CECity.com, Inc.;
• Edwin C. Hedblom, Clinical Research 3M Skin & Wound Care; and
• Peyton Howell, president, consulting services and senior vice president, business development for AmerisourceBergen.
The new Trustees were installed as of July 2011, and will serve a 3-year term.
FMCP is focused on leadership, research and education for managed care pharmacists, according to Norrie Thomas, FMCP's interim executive director.
“The trustees will advise the strategic development of internship programs that examine the role of our profession over the next 5 years with a view toward creating innovation and identifying the best way to foster the development of future leaders,” Thomas told Formulary.
According to Thomas, at the AMCP educational meetings in October, FMCP will present a pre-meeting devoted to research in managed care pharmacy. FMCP will publish a proceedings capturing the presentations and discussions that will guide the research agenda for managed care pharmacy.
“Later this year, in December, the trustees will meet with industry experts as well as academia from across the United States to discuss the changes impacting our profession and will design innovative pilot programs for managed care preceptors and student internship programs,” Thomas said.
The 4 new trustees join President Richard A. Zabinski, PharmD, FAMCP, OptumHealth (A division of UnitedHealth Group); Vice President John Hopkins, BS Pharm, Rocky Mountain Health Plans; Treasurer Robert DeLuca, BS Pharm, Archimedes Pharma US Inc.; and Trustees Ms. Shawn Burke, BS Pharm, FAMCP, RPH, Coventry Health Care; David L. Clark, BS Pharm, MBA, RPH; Perry Cohen, The Pharmacy Group, LLC; William K. Fleming, PharmD, RPh, Humana, Inc.; Kathleen Kaa, PhD, RPh, Genentech, Inc.; Brian Sweet, BS Pharm, MBA, AstraZeneca Pharmaceuticals.
David Calabrese of OptumRx Talks Top Three Drugs in Pipeline, Industry Trends in Q2
July 1st 2020In this week's episode of Tuning Into The C-Suite podcast, MHE's Briana Contreras chatted with David Calabrese, R.Ph, MHP, who is senior vice president and chief pharmacy officer of pharmacy care services company, OptumRx. David is also a member of Managed Healthcare Executives’ Editorial Advisory Board. During the discussion, he shared the OptumRx Quarter 2 Drug Pipeline Insights Report of 2020. Some of the information shared includes the three notable drugs currently being reviewed or those that have been recently approved by the FDA. Also discussed were any interesting industry trends to watch for.
Listen